Advertisement

Ads Placeholder
Loading...

DarioHealth Corp.

DRIO•NASDAQ
Healthcare
Medical - Diagnostics & Research
$8.40
$0.30(3.70%)
U.S. Market opens in 19h 7m

DarioHealth Corp. (DRIO) Stock Overview

Explore DarioHealth Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap61.3M
P/E Ratio6.75
EPS (TTM)$-10.12
ROE0.88%
Fundamental Analysis

AI Price Forecasts

1 Month$8.97
3 Months$15.59
1 Year Target$19.56

DRIO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of DarioHealth Corp. (DRIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.68, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $19.56.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 6.75 and a market capitalization of 61.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.70%
5-Day Change
-2.21%
1-Month Change
-18.45%
3-Month Change
-20.15%
6-Month Change
-48.62%
Year-to-Date (YTD) Change
-20.15%
1-Year Change
-27.15%
3-Year Change
-89.31%
5-Year Change
-97.67%
All-Time (Max) Change
-99.42%

Contact Information

https://www.mydario.com
833 914 3796
18 West 18th Street, New York City, NY, 10011

Company Facts

1,960 Employees
IPO DateMar 14, 2016
CountryUS
Actively Trading

Frequently Asked Questions